Cisplatin and hydration
WebProphylaxis and treatment Prevention and management of cisplatin nephrotoxicity ID: 184 v.3 Endorsed This document is an evidence based summary to complement treatment … WebCisplatin(cis-dichlorodiammineplatinum)–platinum coordination complex is an effective chemotherapy against a wide spectrum of tumors such as testicular, head and neck, ovarian, lung, cervical, and bladder cancers. Nephrotoxicity is the dose-limiting toxicity of cisplatin. Cisplatin induces the production of ROS
Cisplatin and hydration
Did you know?
WebOct 7, 2024 · Cisplatin is one of the most widely used chemotherapeutic drugs in the treatment of a wide range of pediatric and adult malignances. However, it has various side effects which limit its use. Cisplatin mouse models are widely used in studies investigating cisplatin therapeutic and toxic effects. WebSep 4, 2013 · Cisplatin was administered with pre- and post-hydration containing 10 mEq of potassium chloride in 500 ml of fluid over a 60-min period. Immediately before the administration of cisplatin, mannitol (20%, 200 ml) was administered as forced diuresis over 30 min. And magnesium sulfate (8 mEq) was added to pre-hydration. Results
WebFigure 1. An example of chemotherapy regimen: cisplatin and pemetrexed. - "Short hydration in chemotherapy containing cisplatin (≥75 mg/m2) for patients with lung cancer: a prospective study." WebIn conventional treatment regimens employing doses of cisplatin of less than 100 mg/m (2) in patients with normal renal function, pre- and post-hydration (3 l/m (2) at least 12 h pre-cisplatin and 24 h post-cisplatin) alone should be routinely used.
WebJan 7, 2024 · Cisplatin has a well-documented array of toxic side-effects, of which some are potentially irreversible, including nephrotoxicity. 1, 2 Accordingly, cisplatin infusion is usually combined with saline to hydrate and mannitol infusion to promote osmotic diuresis to prevent permanent damage to the renal tubules. 2 – 4 WebCisplatin for injection is a highly emetogenic antineoplastic agent; premedicate with anti-emetic agents; without antiemetic therapy, marked nausea and vomiting occur in almost …
WebFigure 1. An example of chemotherapy regimen: cisplatin and pemetrexed. - "Short hydration in chemotherapy containing cisplatin (≥75 mg/m2) for patients with lung …
WebApr 12, 2024 · Cisplatin is a platinum-based chemotherapy agent that currently used as front-line therapy in the treatment of various solid organ cancers, including head and neck, lung, testis, ovary, breast, bladder cancer and sarcoma [1–7]. The therapeutic effects of cisplatin are significantly improved by dose escalation. sharekhan education mumbaiWebHyponatremia of grade 3 or above developed in 30.7% of the generic CDDP group compared to 15.1% of the brand-name CDDP group ( P =0.011). Multivariate analysis showed that the use of generic CDDP increased the incidence of hyponatremia (odds ratio =5.661, 95% confidence interval =1.403–22.839; P =0.015). Conclusion: Oncologists … sharekhan education portalWebBefore and/or after the cisplatin infusion, extra IV fluids are given and care is taken to ensure adequate hydration before both during and after cisplatin, to protect your … poor in frenchhttp://school.freekaoyan.com/hongkong/cuhk/2024/06-27/1498578834645114.shtml sharekhan education micky galaWebApr 12, 2024 · All doses of cisplatin were diluted in 500 ml of 0.9% saline and infused over 2–3 h. Patients in the mannitol cohort received 20 g admixed in the 0.9% 100 ml saline prehydration. All patients received antiemetic premedication such as dexamethasone, a H 2 receptor blocker and diphenhydramine. Assessment of outcome sharekhan education feesWebJun 23, 2024 · Depending on the protocol, 1 - 2 litres pre-hydration. The patient must have urinated a litre minimum before we proceed. Our cisplat goes in 250 mls usually giving us a final volume of 340 mls. We used to pass Mannitol concurrently but that's now been … sharekhan education videosWebJun 27, 2024 · 摘要Aims: To ascertain the efficacy and toxicity of cisplatin in combination with adriamycin for patients with metastatic and/or locoregional recurrent nasopharyngeal carcinoma. Patients and Methods: A phase II trial combining cisplatin and adriamycin was conducted in 15 patients with metastatic nasopharyngeal carcinoma. poor in heart meaning